Currency: CNY
Period
Q1 FY2024 Earnings
--
646.00M
0.58
Strong Buy
May 14, 2024
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Shanghai Haohai Biotechnology Co., Ltd. 2023 Annual Report (after correction)
Apr 30 00:00
Corrections to the 2023 Annual Report of Shanghai Haohai Biotechnology Co., Ltd.
Shanghai Haohai Biotechnology Co., Ltd. Report for the first quarter of 2024
Summary of the 2023 annual report of Shanghai Haohai Biotechnology Co., Ltd.
Mar 9 00:00
Read more
Updated: May 14, 2024
Buy
Hold
Underperform
Sell
No Data